Lemtrada®

Lemtrada (alemtuzumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a CD52-directed cytolytic monoclonal antibody for the treatment of Multiple Sclerosis (MS). While Lemtrada does not cure MS it may help make relapses less frequent.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

Sanofi Genzyme

CLASS:
Biologics (CD52 monoclonal antibodies)
WHAT IT TREATS:

Relapsing and remitting forms of Multiple Sclerosis (MS) and secondary progressive forms of the disease

PRESCRIBED BY:

Neurologists

HOW ADMINISTERED:
IV infusion
FREQUENCY:

Daily for 5 days then once a year

Length of infusion:
Five hours or more